Cargando…

Seroprevalence, predictors and estimated incidence of maternal and neonatal Herpes Simplex Virus Type 2 infection in semi-urban women in Kilifi, Kenya

BACKGROUND: Herpes Simplex Virus type 2 (HSV-2) has public health importance as a leading cause of genital ulcers, a co-factor in HIV-1 acquisition and transmission and as a cause of neonatal herpes infections. Little is known of its epidemiology and burden in Coastal Kenya. METHODS: We screened pla...

Descripción completa

Detalles Bibliográficos
Autores principales: Nyiro, Joyce U, Sanders, Eduard J, Ngetsa, Caroline, Wale, Steve, Awuondo, Ken, Bukusi, Elizabeth, Price, Matthew A, Amornkul, Pauli N, James Nokes, D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123214/
https://www.ncbi.nlm.nih.gov/pubmed/21627803
http://dx.doi.org/10.1186/1471-2334-11-155
_version_ 1782206945800749056
author Nyiro, Joyce U
Sanders, Eduard J
Ngetsa, Caroline
Wale, Steve
Awuondo, Ken
Bukusi, Elizabeth
Price, Matthew A
Amornkul, Pauli N
James Nokes, D
author_facet Nyiro, Joyce U
Sanders, Eduard J
Ngetsa, Caroline
Wale, Steve
Awuondo, Ken
Bukusi, Elizabeth
Price, Matthew A
Amornkul, Pauli N
James Nokes, D
author_sort Nyiro, Joyce U
collection PubMed
description BACKGROUND: Herpes Simplex Virus type 2 (HSV-2) has public health importance as a leading cause of genital ulcers, a co-factor in HIV-1 acquisition and transmission and as a cause of neonatal herpes infections. Little is known of its epidemiology and burden in Coastal Kenya. METHODS: We screened plasma samples for HSV-2 infection from 826 women aged 15-34 years who participated in an HIV-1 survey in Kilifi in 2004. The sample comprised 563 women selected randomly from a demographic surveillance system (DSS) and 263 women who presented for voluntary counseling and testing (VCT). Predictors for HSV-2 seropositivity were determined using multivariate logistic regression. The incidence of HSV-2 infection and risk of neonatal herpes were estimated by a simple catalytic model fitted to age-seroprevalence data. RESULTS: HSV-2 prevalence was 32% in the DSS recruits vs. 44% in the VCT recruits (P < 0.001), while, HIV-1 prevalence was 8% in the DSS recruits vs. 12% in the VCT recruits (P = 0.12). Independent risk factors for HSV-2 infection in all women were: older age (30-34 years; odds ratio (OR) 10.5, 95% confidence interval (CI): 5.2 - 21.0), recruitment from VCT (OR 1.5, 95% CI: 1.1 - 2.1), history of genital ulcers (OR 1.7, 95% CI: 1.2 - 2.3) and HIV infection (OR 2.7, 95% CI: 1.6-4.6). Education beyond primary (OR 0.7, 95% CI: 0.5 - 0.9) was inversely associated with HSV-2 infection. In the DSS sample, HSV-2 incidence was estimated at 4 cases (95% CI: 3.3 - 4.4) per 100 women per year, 17 cases (95% CI: 16-18) per 1,000 pregnancies per year and 33 neonatal cases (95% CI: 31-36) per 100,000 births per year. CONCLUSIONS: HSV-2 transmission is rapid following the onset of sexual activity and likely to result in a significant burden of genital ulcer disease. Nevertheless, the burden of neonatal HSV-2 can be predicted to be low. Educating young women about HSV-2 infection may help in reducing its burden in this semi-urban population.
format Online
Article
Text
id pubmed-3123214
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31232142011-06-25 Seroprevalence, predictors and estimated incidence of maternal and neonatal Herpes Simplex Virus Type 2 infection in semi-urban women in Kilifi, Kenya Nyiro, Joyce U Sanders, Eduard J Ngetsa, Caroline Wale, Steve Awuondo, Ken Bukusi, Elizabeth Price, Matthew A Amornkul, Pauli N James Nokes, D BMC Infect Dis Research Article BACKGROUND: Herpes Simplex Virus type 2 (HSV-2) has public health importance as a leading cause of genital ulcers, a co-factor in HIV-1 acquisition and transmission and as a cause of neonatal herpes infections. Little is known of its epidemiology and burden in Coastal Kenya. METHODS: We screened plasma samples for HSV-2 infection from 826 women aged 15-34 years who participated in an HIV-1 survey in Kilifi in 2004. The sample comprised 563 women selected randomly from a demographic surveillance system (DSS) and 263 women who presented for voluntary counseling and testing (VCT). Predictors for HSV-2 seropositivity were determined using multivariate logistic regression. The incidence of HSV-2 infection and risk of neonatal herpes were estimated by a simple catalytic model fitted to age-seroprevalence data. RESULTS: HSV-2 prevalence was 32% in the DSS recruits vs. 44% in the VCT recruits (P < 0.001), while, HIV-1 prevalence was 8% in the DSS recruits vs. 12% in the VCT recruits (P = 0.12). Independent risk factors for HSV-2 infection in all women were: older age (30-34 years; odds ratio (OR) 10.5, 95% confidence interval (CI): 5.2 - 21.0), recruitment from VCT (OR 1.5, 95% CI: 1.1 - 2.1), history of genital ulcers (OR 1.7, 95% CI: 1.2 - 2.3) and HIV infection (OR 2.7, 95% CI: 1.6-4.6). Education beyond primary (OR 0.7, 95% CI: 0.5 - 0.9) was inversely associated with HSV-2 infection. In the DSS sample, HSV-2 incidence was estimated at 4 cases (95% CI: 3.3 - 4.4) per 100 women per year, 17 cases (95% CI: 16-18) per 1,000 pregnancies per year and 33 neonatal cases (95% CI: 31-36) per 100,000 births per year. CONCLUSIONS: HSV-2 transmission is rapid following the onset of sexual activity and likely to result in a significant burden of genital ulcer disease. Nevertheless, the burden of neonatal HSV-2 can be predicted to be low. Educating young women about HSV-2 infection may help in reducing its burden in this semi-urban population. BioMed Central 2011-05-31 /pmc/articles/PMC3123214/ /pubmed/21627803 http://dx.doi.org/10.1186/1471-2334-11-155 Text en Copyright ©2011 Nyiro et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Nyiro, Joyce U
Sanders, Eduard J
Ngetsa, Caroline
Wale, Steve
Awuondo, Ken
Bukusi, Elizabeth
Price, Matthew A
Amornkul, Pauli N
James Nokes, D
Seroprevalence, predictors and estimated incidence of maternal and neonatal Herpes Simplex Virus Type 2 infection in semi-urban women in Kilifi, Kenya
title Seroprevalence, predictors and estimated incidence of maternal and neonatal Herpes Simplex Virus Type 2 infection in semi-urban women in Kilifi, Kenya
title_full Seroprevalence, predictors and estimated incidence of maternal and neonatal Herpes Simplex Virus Type 2 infection in semi-urban women in Kilifi, Kenya
title_fullStr Seroprevalence, predictors and estimated incidence of maternal and neonatal Herpes Simplex Virus Type 2 infection in semi-urban women in Kilifi, Kenya
title_full_unstemmed Seroprevalence, predictors and estimated incidence of maternal and neonatal Herpes Simplex Virus Type 2 infection in semi-urban women in Kilifi, Kenya
title_short Seroprevalence, predictors and estimated incidence of maternal and neonatal Herpes Simplex Virus Type 2 infection in semi-urban women in Kilifi, Kenya
title_sort seroprevalence, predictors and estimated incidence of maternal and neonatal herpes simplex virus type 2 infection in semi-urban women in kilifi, kenya
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123214/
https://www.ncbi.nlm.nih.gov/pubmed/21627803
http://dx.doi.org/10.1186/1471-2334-11-155
work_keys_str_mv AT nyirojoyceu seroprevalencepredictorsandestimatedincidenceofmaternalandneonatalherpessimplexvirustype2infectioninsemiurbanwomeninkilifikenya
AT sanderseduardj seroprevalencepredictorsandestimatedincidenceofmaternalandneonatalherpessimplexvirustype2infectioninsemiurbanwomeninkilifikenya
AT ngetsacaroline seroprevalencepredictorsandestimatedincidenceofmaternalandneonatalherpessimplexvirustype2infectioninsemiurbanwomeninkilifikenya
AT walesteve seroprevalencepredictorsandestimatedincidenceofmaternalandneonatalherpessimplexvirustype2infectioninsemiurbanwomeninkilifikenya
AT awuondoken seroprevalencepredictorsandestimatedincidenceofmaternalandneonatalherpessimplexvirustype2infectioninsemiurbanwomeninkilifikenya
AT bukusielizabeth seroprevalencepredictorsandestimatedincidenceofmaternalandneonatalherpessimplexvirustype2infectioninsemiurbanwomeninkilifikenya
AT pricematthewa seroprevalencepredictorsandestimatedincidenceofmaternalandneonatalherpessimplexvirustype2infectioninsemiurbanwomeninkilifikenya
AT amornkulpaulin seroprevalencepredictorsandestimatedincidenceofmaternalandneonatalherpessimplexvirustype2infectioninsemiurbanwomeninkilifikenya
AT jamesnokesd seroprevalencepredictorsandestimatedincidenceofmaternalandneonatalherpessimplexvirustype2infectioninsemiurbanwomeninkilifikenya